Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124908372 | 12490837 | 2 | F | 20101220 | 20160803 | 20160623 | 20160811 | EXP | DK-ASTRAZENECA-2016SE65449 | ASTRAZENECA | 19598.00 | DY | F | Y | 56.00000 | KG | 20160811 | CN | DK | DK |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124908372 | 12490837 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 39240 | MG | U | U | 21366 | 20 | MG | TABLET | QD | |||
124908372 | 12490837 | 2 | C | ANCOZAN | LOSARTAN POTASSIUM | 1 | 0 | ||||||||||||
124908372 | 12490837 | 3 | C | CLORIOCARD | 2 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124908372 | 12490837 | 1 | Hypercholesterolaemia |
124908372 | 12490837 | 3 | Thrombosis prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124908372 | 12490837 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124908372 | 12490837 | Cupulolithiasis | |
124908372 | 12490837 | Dizziness | |
124908372 | 12490837 | Insomnia | |
124908372 | 12490837 | Nausea | |
124908372 | 12490837 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124908372 | 12490837 | 1 | 20101215 | 20160429 | 0 |